Report Summary
Eternity Insights has published a new study on Global Endometriosis Drugs Market focusing on key segments and regions. This in-depth research report highlights the market and competitive intelligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Endometriosis Drugs Market.
The report considers 2019-2022 as historic period, 2023 as base year, and 2024-2034 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Endometriosis Drugs Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Endometriosis Drugs Market Size, 2019-2034 (USD Million)

To learn more about this report
Global Endometriosis Drugs Market Segmentation:
Endometriosis Drugs Market, By Age Group
Endometriosis Drugs Market, By Study Phases
- Early Phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
Endometriosis Drugs Market, By Study Type
- Interventional
- Observational
Endometriosis Drugs Market, By Therapy Type
- Pain Management
- Hormonal Therapy
Endometriosis Drugs Market, By Drug Class
- Gonadotropins Releasing Hormone Agonists
- Progestin
- Non-Steroidal Anti-Inflammatory Drugs
- Oral Contraceptive Pills
Endometriosis Drugs Market, By Route of Administration
- Oral
- Nasal Spray
- Intrauterine Systems
- Parenteral
Endometriosis Drugs Market, By Distribution Channel
- Pharmacies
- E-Commerce
- Others

To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Endometriosis Drugs market in terms of demand generation. The Endometriosis Drugs market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Endometriosis Drugs market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Endometriosis Drugs Market Taxonomy:

To learn more about this report
Global Endometriosis Drugs Market Competitive Landscape
The global Endometriosis Drugs market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the Report:
- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Bayer AG
- Debiopharm Group
- Evotec AG
- Kissei Pharmaceutical Co. Ltd.
- Neurocrine Biosciences Inc.
- ObsEva SA
- Pfizer Inc.
- Repros Therapeutics Inc.
- Takeda Pharmaceutical Company Limited
- Other Players of Specific Interest can be added based on the requirement
Market Segmentation
Report Attributes |
Details |
The market size value in 2023 |
USD XX.XX Million |
CAGR (2024 - 2034) |
XX.XX % |
The Revenue forecast in 2034 |
USD XX.XX Million |
Base year for estimation |
2023 |
Historical data |
2019-2022 |
Forecast period |
2024-2034 |
Quantitative units |
- Revenue in USD Million
- CAGR from 2024 to 2034
|
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered |
By Age Group Outlook, Distribution Channel Outlook, Regional Outlook |
By Age Group Outlook |
Child, Adult, Senior |
By Distribution Channel Outlook |
Pharmacies, E-Commerce, Others |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled |
AbbVie Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Debiopharm Group, Evotec AG, Kissei Pharmaceutical Co. Ltd., Neurocrine Biosciences Inc., ObsEva SA, Pfizer Inc., Repros Therapeutics Inc., Takeda Pharmaceutical Company Limited |
Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the Stakeholders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Global Endometriosis Drugs Industry Market Research Report
1 Endometriosis Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Endometriosis Drugs
1.3 Endometriosis Drugs Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Endometriosis Drugs Value ($) and Growth Rate from 2014-2026
1.4 Market Segmentation
1.4.1 Types of Endometriosis Drugs
1.4.2 Applications of Endometriosis Drugs
1.4.3 Research Regions
1.4.3.1 North America Endometriosis Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.2 Europe Endometriosis Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.3 China Endometriosis Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.4 Japan Endometriosis Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.5 Middle East & Africa Endometriosis Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.6 India Endometriosis Drugs Production Value ($) and Growth Rate (2014-2019)
1.4.3.7 South America Endometriosis Drugs Production Value ($) and Growth Rate (2014-2019)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Endometriosis Drugs
1.5.1.2 Growing Market of Endometriosis Drugs
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Endometriosis Drugs Analysis
2.2 Major Players of Endometriosis Drugs
2.2.1 Major Players Manufacturing Base and Market Share of Endometriosis Drugs in 2018
2.2.2 Major Players Product Types in 2018
2.3 Endometriosis Drugs Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Endometriosis Drugs
2.3.3 Raw Material Cost of Endometriosis Drugs
2.3.4 Labor Cost of Endometriosis Drugs
2.4 Market Channel Analysis of Endometriosis Drugs
2.5 Major Downstream Buyers of Endometriosis Drugs Analysis
3 Global Endometriosis Drugs Market, by Type
3.1 Global Endometriosis Drugs Value ($) and Market Share by Type (2014-2019)
3.2 Global Endometriosis Drugs Production and Market Share by Type (2014-2019)
3.3 Global Endometriosis Drugs Value ($) and Growth Rate by Type (2014-2019)
3.4 Global Endometriosis Drugs Price Analysis by Type (2014-2019)
4 Endometriosis Drugs Market, by Application
4.1 Global Endometriosis Drugs Consumption and Market Share by Application (2014-2019)
4.2 Downstream Buyers by Application
4.3 Global Endometriosis Drugs Consumption and Growth Rate by Application (2014-2019)
5 Global Endometriosis Drugs Production, Value ($) by Region (2014-2019)
5.1 Global Endometriosis Drugs Value ($) and Market Share by Region (2014-2019)
5.2 Global Endometriosis Drugs Production and Market Share by Region (2014-2019)
5.3 Global Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.4 North America Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.5 Europe Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.6 China Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.7 Japan Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.8 Middle East & Africa Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.9 India Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
5.10 South America Endometriosis Drugs Production, Value ($), Price and Gross Margin (2014-2019)
6 Global Endometriosis Drugs Production, Consumption, Export, Import by Regions (2014-2019)
6.1 Global Endometriosis Drugs Consumption by Regions (2014-2019)
6.2 North America Endometriosis Drugs Production, Consumption, Export, Import (2014-2019)
6.3 Europe Endometriosis Drugs Production, Consumption, Export, Import (2014-2019)
6.4 China Endometriosis Drugs Production, Consumption, Export, Import (2014-2019)
6.5 Japan Endometriosis Drugs Production, Consumption, Export, Import (2014-2019)
6.6 Middle East & Africa Endometriosis Drugs Production, Consumption, Export, Import (2014-2019)
6.7 India Endometriosis Drugs Production, Consumption, Export, Import (2014-2019)
6.8 South America Endometriosis Drugs Production, Consumption, Export, Import (2014-2019)
7 Global Endometriosis Drugs Market Status and SWOT Analysis by Regions
7.1 North America Endometriosis Drugs Market Status and SWOT Analysis
7.2 Europe Endometriosis Drugs Market Status and SWOT Analysis
7.3 China Endometriosis Drugs Market Status and SWOT Analysis
7.4 Japan Endometriosis Drugs Market Status and SWOT Analysis
7.5 Middle East & Africa Endometriosis Drugs Market Status and SWOT Analysis
7.6 India Endometriosis Drugs Market Status and SWOT Analysis
7.7 South America Endometriosis Drugs Market Status and SWOT Analysis
8 Competitive Landscape
8.1 Competitive Profile
8.2 Speciality European Pharma
8.2.1 Company Profiles
8.2.2 Endometriosis Drugs Product Introduction
8.2.3 Speciality European Pharma Production, Value ($), Price, Gross Margin 2014-2019
8.2.4 Speciality European Pharma Market Share of Endometriosis Drugs Segmented by Region in 2018
8.3 Pfizer
8.3.1 Company Profiles
8.3.2 Endometriosis Drugs Product Introduction
8.3.3 Pfizer Production, Value ($), Price, Gross Margin 2014-2019
8.3.4 Pfizer Market Share of Endometriosis Drugs Segmented by Region in 2018
8.4 PregLem
8.4.1 Company Profiles
8.4.2 Endometriosis Drugs Product Introduction
8.4.3 PregLem Production, Value ($), Price, Gross Margin 2014-2019
8.4.4 PregLem Market Share of Endometriosis Drugs Segmented by Region in 2018
8.5 SK Chemicals
8.5.1 Company Profiles
8.5.2 Endometriosis Drugs Product Introduction
8.5.3 SK Chemicals Production, Value ($), Price, Gross Margin 2014-2019
8.5.4 SK Chemicals Market Share of Endometriosis Drugs Segmented by Region in 2018
8.6 Roivant Sciences
8.6.1 Company Profiles
8.6.2 Endometriosis Drugs Product Introduction
8.6.3 Roivant Sciences Production, Value ($), Price, Gross Margin 2014-2019
8.6.4 Roivant Sciences Market Share of Endometriosis Drugs Segmented by Region in 2018
8.7 ValiPharma
8.7.1 Company Profiles
8.7.2 Endometriosis Drugs Product Introduction
8.7.3 ValiPharma Production, Value ($), Price, Gross Margin 2014-2019
8.7.4 ValiPharma Market Share of Endometriosis Drugs Segmented by Region in 2018
8.8 AbbVie
8.8.1 Company Profiles
8.8.2 Endometriosis Drugs Product Introduction
8.8.3 AbbVie Production, Value ($), Price, Gross Margin 2014-2019
8.8.4 AbbVie Market Share of Endometriosis Drugs Segmented by Region in 2018
8.9 Kissei Pharmaceutical
8.9.1 Company Profiles
8.9.2 Endometriosis Drugs Product Introduction
8.9.3 Kissei Pharmaceutical Production, Value ($), Price, Gross Margin 2014-2019
8.9.4 Kissei Pharmaceutical Market Share of Endometriosis Drugs Segmented by Region in 2018
8.10 Astellas Pharma
8.10.1 Company Profiles
8.10.2 Endometriosis Drugs Product Introduction
8.10.3 Astellas Pharma Production, Value ($), Price, Gross Margin 2014-2019
8.10.4 Astellas Pharma Market Share of Endometriosis Drugs Segmented by Region in 2018
8.11 AstraZeneca
8.11.1 Company Profiles
8.11.2 Endometriosis Drugs Product Introduction
8.11.3 AstraZeneca Production, Value ($), Price, Gross Margin 2014-2019
8.11.4 AstraZeneca Market Share of Endometriosis Drugs Segmented by Region in 2018
8.12 Isifer
8.12.1 Company Profiles
8.12.2 Endometriosis Drugs Product Introduction
8.12.3 Isifer Production, Value ($), Price, Gross Margin 2014-2019
8.12.4 Isifer Market Share of Endometriosis Drugs Segmented by Region in 2018
8.13 Neurocrine Biosciences
8.13.1 Company Profiles
8.13.2 Endometriosis Drugs Product Introduction
8.13.3 Neurocrine Biosciences Production, Value ($), Price, Gross Margin 2014-2019
8.13.4 Neurocrine Biosciences Market Share of Endometriosis Drugs Segmented by Region in 2018
8.14 ObsEva
8.14.1 Company Profiles
8.14.2 Endometriosis Drugs Product Introduction
8.14.3 ObsEva Production, Value ($), Price, Gross Margin 2014-2019
8.14.4 ObsEva Market Share of Endometriosis Drugs Segmented by Region in 2018
8.15 Philogen
8.15.1 Company Profiles
8.15.2 Endometriosis Drugs Product Introduction
8.15.3 Philogen Production, Value ($), Price, Gross Margin 2014-2019
8.15.4 Philogen Market Share of Endometriosis Drugs Segmented by Region in 2018
8.16 Repros Therapeutics
8.16.1 Company Profiles
8.16.2 Endometriosis Drugs Product Introduction
8.16.3 Repros Therapeutics Production, Value ($), Price, Gross Margin 2014-2019
8.16.4 Repros Therapeutics Market Share of Endometriosis Drugs Segmented by Region in 2018
8.17 Nippon Shinyaku
8.18 ElexoPharm
8.19 Bayer HealthCare
8.20 Debiopharm
8.21 Addex Therapeutics
8.22 Endoceutics
8.23 Takeda
8.24 Orphagen Pharmaceuticals
8.25 SYNG Pharmaceuticals
8.26 Euroscreen
8.27 Forendo Pharma
8.28 United Pharmaceuticals
9 Global Endometriosis Drugs Market Analysis and Forecast by Type and Application
9.1 Global Endometriosis Drugs Market Value ($) & Volume Forecast, by Type (2019-2026)
9.1.1 Oral Market Value ($) and Volume Forecast (2019-2026)
9.1.2 Parenteral Market Value ($) and Volume Forecast (2019-2026)
9.1.3 Intrauterine Systems Market Value ($) and Volume Forecast (2019-2026)
9.1.4 Nasal Spray Market Value ($) and Volume Forecast (2019-2026)
9.2 Global Endometriosis Drugs Market Value ($) & Volume Forecast, by Application (2019-2026)
9.2.1 Application 1 Market Value ($) and Volume Forecast (2019-2026)
9.2.2 Application 2 Market Value ($) and Volume Forecast (2019-2026)
9.2.3 Application 3 Market Value ($) and Volume Forecast (2019-2026)
9.2.4 Application 4 Market Value ($) and Volume Forecast (2019-2026)
9.2.5 Application 5 Market Value ($) and Volume Forecast (2019-2026)
10 Endometriosis Drugs Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2019-2026)
10.2 Europe Market Value ($) and Consumption Forecast (2019-2026)
10.3 China Market Value ($) and Consumption Forecast (2019-2026)
10.4 Japan Market Value ($) and Consumption Forecast (2019-2026)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2026)
10.6 India Market Value ($) and Consumption Forecast (2019-2026)
10.7 South America Market Value ($) and Consumption Forecast (2019-2026)
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used